Replication of the Teen Outreach Program in the Pacific Northwest

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The Northwest Coalition for Adolescent Health (NWCAH) replicated the Teen Outreach Program (TOP) in five states across the pacific northwest including Idaho, Alaska, Montana, Oregon, and Washington. The purpose of this study is to measure: at the end of the program year, were TOP students less likely than control group students to report ever being pregnant or causing someone to be pregnant?

See also
Status	Clinical Trial	Phase
Completed	`NCT02890628` - Teenage Pregnancies in Refugee and Migrant Adolescents on the Thai-Myanmar Border	N/A
Completed	`NCT02514759` - Replication of the Teen Outreach Program in Kansas City	N/A
Completed	`NCT03029962` - Girl2Girl: Harnessing Text Messaging to Reduce Teenage Pregnancy Among LGB Girls	N/A
Completed	`NCT03265314` - LeadHer, a Gender-specific Teen Pregnancy Prevention Curriculum for Girls 15-19	N/A

NCT number	NCT02514811
Study type	Interventional
Source	Philliber Research & Evaluation
Contact
Status	Completed
Phase	N/A
Start date	September 2011
Completion date	August 2015

Replication of the Teen Outreach Program in the Pacific Northwest

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms